157 related articles for article (PubMed ID: 33306861)
1. Hydatidiform mole diagnostics using circulating gestational trophoblasts isolated from maternal blood.
Sunde L; Singh R; Ravn K; Schelde P; Hansen ES; Uldbjerg N; Niemann I; Hatt L
Mol Genet Genomic Med; 2021 Jan; 9(1):e1565. PubMed ID: 33306861
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of hydatidiform moles using circulating gestational trophoblasts isolated from maternal blood.
Ravn K; Hatt L; Singh R; Schelde P; Hansen ES; Vogel I; Uldbjerg N; Niemann I; Sunde L
Placenta; 2023 Apr; 135():7-15. PubMed ID: 36889013
[TBL] [Abstract][Full Text] [Related]
3. When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease.
McMahon L; Maher GJ; Joyce C; Niemann I; Fisher R; Sunde L
Gynecol Obstet Invest; 2024; 89(3):198-213. PubMed ID: 37245506
[TBL] [Abstract][Full Text] [Related]
4. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
[TBL] [Abstract][Full Text] [Related]
6. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
7. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
8. Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review.
Kalogiannidis I; Kalinderi K; Kalinderis M; Miliaras D; Tarlatzis B; Athanasiadis A
J Assist Reprod Genet; 2018 Jun; 35(6):967-973. PubMed ID: 29737470
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of cell lines derived from complete hydatidiform mole.
Yamamoto E; Niimi K; Kiyono T; Yamamoto T; Nishino K; Nakamura K; Kotani T; Kajiyama H; Shibata K; Kikkawa F
Int J Mol Med; 2017 Sep; 40(3):614-622. PubMed ID: 28713902
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts.
Ladines-Llave CA; Maruo T; Manalo AM; Mochizuki M
Cancer; 1993 Jun; 71(12):4118-23. PubMed ID: 7685239
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles.
Bolze PA; Patrier S; Cheynet V; Oriol G; Massardier J; Hajri T; Guillotte M; Bossus M; Sanlaville D; Golfier F; Mallet F
Placenta; 2016 Mar; 39():116-24. PubMed ID: 26992684
[TBL] [Abstract][Full Text] [Related]
12. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2--Genetics.
Fisher RA; Paradinas FJ; Soteriou BA; Foskett M; Newlands ES
J Pathol; 1997 Feb; 181(2):189-95. PubMed ID: 9120724
[TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
15. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
16. Complete hydatidiform mole with a coexistent embryo.
Baergen RN; Kelly T; McGinniss MJ; Jones OW; Benirschke K
Hum Pathol; 1996 Jul; 27(7):731-4. PubMed ID: 8698320
[TBL] [Abstract][Full Text] [Related]
17. Androgenetic Complete Hydatidiform Moles With p57KIP2-Positive Immunostaining.
Usui H; Sato A; Ota M; Ikeda JI; Shozu M
Am J Clin Pathol; 2020 Nov; 154(6):776-783. PubMed ID: 32686837
[TBL] [Abstract][Full Text] [Related]
18. Genetics of gestational trophoblastic disease.
Fisher RA; Maher GJ
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():29-41. PubMed ID: 33685819
[TBL] [Abstract][Full Text] [Related]
19. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
20. Very early complete hydatidiform mole.
Keep D; Zaragoza MV; Hassold T; Redline RW
Hum Pathol; 1996 Jul; 27(7):708-13. PubMed ID: 8698316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]